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Biliary Complications After Liver Transplantation: 
An 18-Year Single-center Experience
Te-I Chang, Ming-Chi Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu*
Background/Purpose: Biliary complications remain a major weakness of liver transplantation. The pur-
pose of this retrospective study was to determine risk factors associated with biliary complications after
liver transplantation, and how they were managed.
Methods: From October 1989 to December 2007, we collected all variables of interest in 253 consecutive
liver transplant recipients at the National Taiwan University Hospital. Risk factors and the outcome of 
different treatments of the biliary complications were analyzed.
Results: Forty-three (17.0%) of the 253 liver transplant patients developed biliary complications. Bile
leakage and biliary stricture rate was 7.9% and 6.7%, respectively. By univariate analysis, risk factors asso-
ciated with bile leakage were older age, cadaveric liver donation, and use of a T-tube. The only protecting
factor against bile leakage was the use of a straight intrahepatic stent. Risk factors associated with biliary
stricture were rejection and male sex. Multivariate analysis demonstrated that T-tube [odds ratio (OR) = 3.45]
and older age group (OR=7.98) were the only independent risk factors for bile leakage, whereas graft rejection
(OR=4.89) and male sex (OR=5.56) were the only independent risk factors for biliary stricture. Percutaneous
transhepatic cholangiography drainage (37.2%) or computed-tomography-guided drainage (27.9%) was
the most frequent initial treatment. Biliary event-free rate after initial treatment was 67.6% and 66.7% in the
non-surgical and surgical group, respectively.
Conclusion: The risk factors for bile leakage and biliary stricture were different due to different pathogenesis.
Straight biliary stent in our series showed a protective effect against bile leakage. Non-surgical management
can be a highly successful initial treatment, and surgery should be reserved for patients who have failed
conservative treatment.
Key Words: bile leakage, biliary stricture, graft rejection, liver transplantation, percutaneous transhepatic
cholangiography drainage
Liver transplantation (LTx) has become the 
definite treatment for end-stage liver disease.
Over the past two decades, innovations in surgi-
cal techniques, immunosuppressants, and organ
preservatives have brought great improvements in
success rate of LTx. However, postoperative biliary
complications remain the weakest part of LTx,
and have been referred to as the “Achilles’ heel” of
the procedure.1 In the early 1970s, biliary com-
plications such as bile leakage, biliary stricture,
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biliary infections, and biliary stones occurred at
a rate of about 40%.2 Contemporary studies still
report biliary complication rates around 9–32%.3
In the past two decades, duct-to-duct anasto-
mosis and Roux-en-Y choledochojejunostomy
have been the primary techniques of biliary re-
construction.4 The biliary complication rates be-
tween the two techniques have shown discordant
results in different centers.5–7 Choledochocholedo-
chostomy over a T-tube was popular in the early
1980s.6 A T-tube allows convenient cholangiog-
raphy access and monitoring of the biliary tree
and bile flow, but a direct relation between it and
early biliary complications has been reported
(35% with T-tube and 18% without).8 Subsequent
large clinical trials9–12 have led to the conclusion
of not using a T-tube because of its higher biliary
complication rate. Modified straight intrahepatic
stenting has been shown to be superior to the T-
tube method,13 but further trials are necessary to
compare it to the non-stenting group.
To examine the influence of different risk
variables associated with the incidence of biliary
complications, we retrospectively reviewed our
LTx patients at a single center.
Patients and Methods
We retrospectively reviewed 253 consecutive LTx
patients at the National Taiwan University Hospital
between October 1989 and December 2007. There
were 87 pediatric patients (aged < 18 years) and
166 adults. Age at LTx ranged from 4 months to
65 years old, and there were 143 male (56.1%) and
110 female (43.9%) patients.
The clinical characteristics that we recorded
were sex, age at LTx, etiology, age group (pediatric
or adult), donor type (cadaver or living-related),
ischemia time, anastomosis methods (choledo-
chocholedochostomy or Roux-en-Y choledocho-
jejunostomy), use of T-tube or straight intrahepatic
stent, immunosuppressant types (cyclosporine
or tacrolimus), and biopsy-proven rejection. In
our institute, we routinely used either T-tube or
straight intrahepatic stent in every LTx patient.
Biliary complications were documented by
cholangiography or computed tomography. The
methods of cholangiography included T-tube, per-
cutaneous transhepatic or endoscopic retrograde
cholangiography. Bile leakage and biliary stricture
were further divided into anastomotic and non-
anastomotic subgroups. The direct relationship be-
tween bile leak and T-tube removal was recorded
in another subgroup. Biloma was also considered
as a biliary complication but not interpreted as
bile leakage due to its doubtful source relation-
ship. To minimize data complexity, only bile leak-
age and biliary stricture groups were analyzed to
search for possible risk factors.
Analysis of categorical and continuous variables
was performed by χ2 or unpaired t test if appro-
priate. Multivariate logistic regression analysis was
performed on variables found to be significant
in univariate analysis, or with p < 0.25. Statistical
analysis was performed with SPSS version 12.0
software (SPSS Inc., Chicago, IL, USA). Variables
in all analyses with p < 0.05 were considered 
statistically significant.
Results
Biliary complications as a whole
Biliary complications were observed in 43 out of
253 LTx patients. Overall biliary complication rate
was 17.0%, with a bile leakage rate of 7.9% and
biliary stricture rate of 6.7%. Six patients (2.4%)
developed biloma. The time interval between the
operation and the appearance of biliary compli-
cations was 1–1938 days, with a mean of 178 days.
The percentage of biliary complications and time
interval before their appearance and standard
deviations are summarized in Table 1.
Detailed disease etiology is listed in Table 2.
We found that hepatitis-B-related disease was the
most common indication for adult LTx (n = 81 or
48.2%), whereas primary biliary atresia was the
most common indication in the pediatric group
(n = 22 or 66.7%).
Detailed demographic information is shown
in Table 3. Live donor transplantation accounted
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for 66.8% of all LTx. By means of anastomosis,
62% of the patients underwent choledochocho-
ledochostomy and 38% underwent Roux-en-Y
hepatojejunostomy. T-tube was used in the ear-
lier cases of LTx before 2003 (30.4%), and straight
intrahepatic stent, along with a nasogastric feeding
tube, was used in the later cases (69.6%).
Univariate analyses of bile leakage and
biliary stricture
The results of univariate analysis of bile leakage and
biliary stricture rates are shown in Tables 4 and 5.
Risk analysis for bile leakage
The mean age at LTx was older in the bile leakage
group (45.6 years vs. 32.8 years, p = 0.019) than in
those without leakage. Cadaver donor LTx showed a
significantly higher leakage rate (13.1% vs. 5.3%,
p = 0.031) than live donor LTx. The use of a T-tube
also showed a higher bile leakage rate than those
with a straight intrahepatic stent (15.6% vs. 4.5%,
p=0.003). The ischemic time, type of immunosup-
pressant, and the presence of rejection had no sig-
nificant correlation with bile leakage. Multivariate
logistic regression showed that adult age and the
use of a T-tube were the only independent risk
factors associated with bile leakage (Table 6).
Table 1. Type of biliary complications and time
intervals
Type n (%)
Time interval ± SD 
(d)
Bile leakage
Anastomotic 2 (0.8) 29.5 ± 0.7
T-tube 14 (5.5) 85.7 ± 30.0
Non-anastomotic 4 (1.6) 36.8 ± 34.3
Subtotal 20 (7.9)
Stricture 
Anastomotic 15 (5.9) 230.6 ± 240.8
Non-anastomotic 2 (0.8) 1066.0 ± 1233.2
Subtotal 17 (6.7)
Biloma 6 (2.4) 109.3 ± 116.3
Total 43 (17.0) 178.0 ± 320.2
SD = standard deviation.
Table 2. Etiology of liver failure for liver
transplantation
Disease type n (%)
Fulminant liver failure 9 (3.6)
Biliary atresia 67 (26.5)
Chronic HBV infection 81 (32.0)
Cirrhosis HCV infection 34 (13.4)
Autoimmune hepatitis 1 (0.4)
Primary biliary cirrhosis 22 (8.7)
Wilson’s disease 3 (1.2)
Alcoholic 4 (1.6)
Congenital hepatic fibrosis 2 (0.8)
Alagille syndrome 4 (1.6)
Methylmalonic acidemia 3 (1.2)
Primary sclerosing cholangitis 2 (0.8)
PFIC 5 (2.0)
Ornithine transcarbamylase 1 (0.4)
deficiency
Caroli’s disease 1 (0.4)
Urea cycle disorder 2 (0.8)
Hepatoblastoma 3 (1.2)
Glycogen storage disease 2 (0.8)
Hepatic neurogenic tumor 1 (0.4)
HBV+HCV 3 (1.2)
Unknown 3 (1.2)
Total 253 (100)
HBV = hepatitis B virus; HCV = hepatitis C virus; PFIC = progressive
familiar intrahepatic cholestasis.
Table 3. Demographic Information
n (%)
Donation type
Cadaveric 84 (33.2)
Living related 169 (66.8)
Anastomosis type
CDC 157 (62.0)
Roux-en-Y 96 (38.0)
Drainage type
T-tube 77 (30.4)
IHS 176 (69.6)
Immunosuppressant
Cyclosporin 99 (39.1)
Tacrolimus 164 (64.8)
Rejection
Yes 98 (38.1)
No 155 (61.3)
CDC = choledochocholedochostomy; IHS = intrahepatic stent.
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Risk analysis for biliary stricture
The same variables were analyzed for biliary stric-
ture (Tables 5 and 6). Male sex appeared to be as-
sociated with higher biliary stricture incidence
than female sex (9.9% vs. 2.7%, p = 0.024). Live
donor LTx showed a trend toward a higher rate of
biliary stricture than those with cadaver donor LTx
(8.9% vs.2.4%, p=0.052). Patients with biopsy-
proven rejection showed a significantly higher rate
of biliary stricture rate than those without (12.2%
vs. 3.2%, p = 0.05). Age at LTx, ischemic time, and
immunosuppressants did not correlate signifi-
cantly with the development of biliary stricture.
In multivariate analysis (Table 6), female sex
[Odds ratio (OR) = 0.19, p = 0.01] and presence
of rejection (OR = 4.85, p = 0.01) appeared to be
the only independent protective and risk factors
for development of biliary stricture.
Management and outcome
In our 43 patients with biliary complications, only
one with non-anastomotic bile leakage developed
Table 4. Univariate analysis of biliary complications (continuous variable)
No leak Bile leak p No stricture Stricture p
Age (SD), yr 32.8 (23.8) 45.6 (15.3) 0.019* 34.0 (23.6) 31.1 (22.6) 0.621
Ischemia time (SD), min 205 (122) 260 (105) 0.243 212 (125) 167 (54) 0.262
Table 5. Univariate analysis of biliary complications (categorical variables)
Leak (%) p Stricture (%) p
Gender
Male (n = 143) 7.0 0.565 9.9 0.024
Female (n = 110) 9.0 2.7
Type of donation
Cadaveric (n = 84) 13.1 0.031 2.4 0.052
Living related (n = 169) 5.3 8.9
Anastomosis type
CDC (n = 157) 9.6 0.214 5.7 0.423
Roux-en-Y (n = 96) 5.2 8.3
Drain type
T-tube (n = 77) 15.6 0.003* 3.9 0.235
IHS (n = 176) 4.5 8.0
Age group
< 18 (n = 87) 2.3 0.017* 8.0 0.542
> 18 (n = 166) 10.8 6.0
Cyclosporine
Yes (n = 99) 8.1 0.934 5.1 0.395
No (n = 164) 7.8 7.8
Tacrolimus
Yes (n = 164) 7.3 0.638 8.5 0.117
No (n = 99) 9.0 3.4
Rejection
Yes (n = 98) 8.2 0.904 12.2 0.05*
No (n = 155) 7.7 3.2
*p < 0.05. CDC = choledochocholedochostomy; IHS = intrahepatic stent.
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biliary stricture 6 months later. The observation
of late biliary stricture that develops after bile
leakage that has been seen in other studies14–16
was not found in our study. This might be because
in our bile leakage cases, the majority were associ-
ated with the T-tube itself (14/20 patients).
Although there has been a report that up to one-
third of patients who develop symptomatic bile
leakage after T-tube removal,17 most of the T-tube-
associated bile leakage can be managed with
conservative treatment,3 which is less likely to
endanger the graft or cause local ischemia that
lead to biliary stricture.
In our institute, percutaneous transhepatic
cholangiography drainage (PTCD), endoscopic
retrograde cholangiopancreatography or radio-
logically guided external drainage were the initial
choices of treatment of biliary complications.
Drain tubes placed during the operation were kept
in place if drainage function existed. Surgery was
reserved as the last choice of treatment. Our
means of initial management are listed in Table 7.
Treatment success was defined as patients who
were biliary-event-free after the procedure. The
most common initial treatment in our LTx patients
with biliary complications was PTCD (62.8%) or
continuous external drainage (20.9%). Only 14%
of patients underwent surgical treatment. The
overall management success rate was 62.7%. The
success rate in the non-surgical group was 64.9%
and in the surgical group, it was 50%. With re-
gard to different types of biliary complications,
we found that the success rate of non-surgical
management was satisfactory (73.3% in the bile
leakage group, 58.8% in the biliary stricture
group, and 60% in the biloma group).
Discussion
We found that, in univariate analysis, older age,
cadaver liver donation, and use of a T-tube was
associated with higher bile leakage rate. The use
of a straight intrahepatic stent appeared to be pro-
tective against bile leakage. By multivariate analy-
sis, older age and the use of a T-tube were the
only independent risk factors for bile leakage.
With regard to the risk of bile leakage in the older
age group, it might be explained by the fact that
bile leakage usually occurs in choledochochole-
dochostomy, and this procedure was mostly used
in adult LTx patients. On the contrary, the predom-
inant disease etiology in pediatric LTx was biliary
atresia, hence hepatojejunostomy was used for
biliary reconstruction, and this procedure is tra-
ditionally associated with less bile leakage.4 Due
to the short duration of this retrospective study,
we cannot confirm the protective effect of straight
intrahepatic stenting by comparing it to a con-
trol group. This might require a multicenter
prospective study.
In biliary stricture patients, male sex, live do-
nation, and rejection were associated with higher
biliary stricture rate. By multivariate analysis, 
Table 6. Multivariate analysis (logistic regression)
OR (95% CI) p
Bile leakage
Living related 0.71 (0.24–2.12) 0.542
CDC/RYCJ 4.04 (0.89–18.44) 0.071
T-tube/IHS 3.45 (1.02–11.62) 0.045*
Age > 18 yr 7.98 (1.29–49.09) 0.025*
Biliary stricture
Female 0.18 (0.05–0.69) 0.013*
Living related 4.33 (0.77–24.60) 0.097
Tacrolimus 2.47 (0.59–10.33) 0.213
T-tube/IHS 1.65 (0.34–8.12) 0.532
Rejection 4.89 (1.60–14.97) 0.005*
*p < 0.05. OR = odds ratio; CI = confidence interval; CDC = chole-
dochocholedochostomy; RYCJ=Roux-en-Y choledochojejunostomy.
Table 7. Initial management choices
n (%) Success (%)
Operation 6 (14.0) 50.0
ERCP 1 (2.3) 0
PTCD 27 (62.8) 59.3
Continuous external 9 (20.9) 88.9
drainagea
aOriginal drains placed during operation or later under image
guidance. ERCP = endoscopic retrograde cholangiopancreatogra-
phy; PTCD=percutaneous transhepatic cholangiography drainage.
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rejection was the only independent risk factor for
biliary stricture, whereas female sex appeared to
be the only independent protective factor against
biliary stricture. It is demonstrated that the in-
flammation process caused by rejection mediates
myofibroblast proliferation, which causes subse-
quent biliary stricture.16 During literature searches
for the effect of sex upon biliary complications,
we noted that, in earlier studies dating back to
the 1990s,18–20 there was a lower survival rate for
grafts from female donors transplanted to male re-
cipients. This makes it less likely that sex-hormone-
related pathogenesis is the only explanation for
the worse outcome of female livers being trans-
planted into male recipients, and immunological
processes may also play a role.21 Our observations
and this hypothesis still require further work for
elucidation.
Despite the continuous progress in LTx resulting
from various technical and medical advances in
recent years,22 a considerable proportion of LTx
patients still experience biliary complications.23
In our center, the overall biliary complication rate
was 17%. Previous studies24–26 have shown that
risk factors include cytomegalovirus infection,
hepatic artery thrombosis or stenosis, and ABO
blood group incompatibility. One contemporary
study16 has stressed that high donor and recipi-
ent age, high MELD score, longer warm ischemia
time, and different preservation solutions might
contribute to the risk of developing biliary com-
plications. A randomized, controlled multicenter
trial in 200111 clearly led to the abandonment of
T-tube drainage by most LTx centers, due to the
higher biliary complication rate, which we also
observed in our later cases.
Management of biliary complications varies
between centers and may require multiple non-
surgical attempts for successful treatment. In our
experience, non-surgical management such as
PTCD with balloon dilatation has been shown a
satisfactory initial treatment for biliary stricture
with a success rate (59.3%) comparable to that in
obtained previously (59%).15 The reason that we
selectively used PTCD instead of endoscopic ret-
rograde cholangiopancreatography is because the
antegrade procedures of PTCD prevent the in-
crease in infections associated with retrograde
procedures. Most of the bile leakage can be man-
aged with continuous external drainage through
the original drain tubes placed during the opera-
tion, or later under imaging guidance. However,
major bile leakage early after operation should
be managed by early surgical intervention.
The time of occurrence of biliary complications
differed between bile leakage and biliary stric-
ture. Bile leakage occurred earlier (70.3 ± 37.3
days) and biliary stricture occurred later (328.9 ±
472.0 days), and these differences were significant
(p = 0.02). These data were similar to those in pre-
vious studies.14,27 We also observed that, in the
majority of patients (12/14) with T-tube-associated
bile leakage, the complication time interval was
around 3 months postoperatively (84–111 days),
and this was highly associated with the time when
we removed the T-tube.
In summary, biliary complications continued
to cause significant morbidity in our LTx patients,
in a multifactorial manner. We were able to identify
several risk factors and have improved our tech-
nique by using straight intrahepatic stents instead
of T-tubes. The management of our patients using
non-surgical methods was satisfactory and necessi-
tated the use of PTCD or continuous drainage for
primary management of biliary complications.
This study has implications for further research
into graft rejection and hepatic immunological
response, and perhaps could lead to innovative
studies about the impact of sex distinction on
biliary complications after LTx.
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